New Swedish research reveals why autism diagnoses differ between males and females and how awareness is closing the gender gap in autism spectrum disorder.
A new autism theory links symptoms to brain energy deficits. Discover how impaired glucose metabolism may affect behavior, speech, and sensory processing.
Leucovorin may help ASD with FRAAs by bypassing blocked folate transport to the brain. Learn how folinic acid supports communication and treats cerebral folate deficiency.
FRAT® test detects folate receptor autoantibodies linked to autism, cerebral folate deficiency, and NTDs—enabling early diagnosis and targeted folinic acid treatment.
Explore how folate receptor alpha autoantibodies (FRAAs) disrupt brain folate transport and contribute to autism spectrum disorder, cerebral folate deficiency, and targeted treatment insights.
FRAT® testing prior to leucovorin therapy ensures accurate diagnosis, personalized dosing, and better outcomes in cerebral folate deficiency and ASD.
Rising autism prevalence and the FDA approval of leucovorin highlight a targeted metabolic approach for ASD linked to cerebral folate deficiency.
Leucovorin demand is rising in ASD care. Learn why folic acid is not an alternative and may worsen cerebral folate deficiency.
Learn how FRAT® helps explain unexplained autism symptoms by detecting folate receptor autoantibodies affecting the brain.
FRAT® testing before folinic acid therapy identifies folate receptor autoantibodies, enabling precise, effective treatment for cerebral folate deficiency and autism.